OVERVIEW

Society for Birth Defects Research and Prevention (BDRP) 61st Annual Meeting is organized by Society for Birth Defects Research and Prevention (BDRP) and will be held from Jun 24 - Jul 01, 2021.

The theme of the 2021 meeting is “Building Bridges in Birth Defects Research and Prevention: From Innovation to Application”

Main Conference: June 24 - July 1, 2021
Education Courses: July 15, 22, 29, 2021

Description:
Birth defects and reproductive and developmentally-mediated disorders constitute a major public health concern in the world today. Human development can be affected not only by drugs and chemicals but also by diet, genetics, maternal health, and socioeconomic factors. The Society for Birth Defects Research and Prevention strives to understand and protect against potential hazards to developing embryos, fetuses, children, and adults by bringing together scientific knowledge from diverse fields.

Our Annual Meeting provides the opportunity to promote our shared vision and scientific identity as researchers focused on the causes, manifestations, intervention, and prevention of birth defects and disorders of developmental origin. Scientific sessions highlight the latest scientific research in birth defects, diseases of developmental origin, and cutting-edge technologies.

Scientific event that provides professionals and scientists who span the breadth of academia, industry, regulatory agencies, consulting companies, and clinical specialties with a forum to exchange knowledge and ideas that promote and expand the value of birth defect research and prevention.

Why Attend the BDRP 61st Annual Meeting?
Birth defects and developmentally-mediated disorders constitute a major public health concern in the world today. Human development can be affected by drugs, chemicals, infectious diseases, diet, genetics, and maternal health as well as and socioeconomic factors. Understanding and protecting against potential hazards to developing embryos, fetuses, and children requires advanced scientific knowledge from diverse and novel fields such as cell and molecular biology, developmental biology and toxicology, computational modeling, genetics, and epidemiology. The science is put into practice in the areas of prenatal medicine, pediatrics, obstetrics, neonatology, medical genetics, counseling, product safety, risk assessment, and governmental regulations.

• Researchers whose cutting-edge science can be applied to birth defects research such as research with stem cells, adverse outcomes pathways, computational toxicology, genomics/genetics, mechanistic toxicology, proteomics, or metabolomics.
• Clinicians involved in early diagnosis of birth defects, technologies to identify birth defects or adverse pregnancy outcomes, identification of chemicals and pathogens that affect pregnancy and development.
• Epidemiologists working to recognize developmental disabilities.
• Regulators responsible for interpreting and managing regulations based on reproductive and developmental endpoints.
• Developmental and Reproductive Toxicologists who develop and/or test pharmaceuticals or chemicals for development and reproductive effects.
• Pharmacologists who develop and design new drugs and chemicals for use during pregnancy and early childhood.
• Educators teaching developmental and reproductive biology/toxicology, serve as mentors to students, or develop training materials for scientists, clinicians, or pregnant women.
• Graduate Students and Postdoctoral Fellows with a desire to learn more in developmental or reproductive toxicology, and diseases of developmental origin, and who want a career in government, academia, or industry in the field of birth defects research.

The 61st Annual Meeting program offers an exciting variety of scientific sessions on topics including:
• Approaches for Mechanistic Evidence Analysis in Hazard Evaluation of Reproductive Toxicology Data
• The Effects of Water Fluoridation on Neurodevelopment and Other Health Outcomes
• Neglected Diseases/Neglected Patients
• Cannabis in Pregnancy and Through Generations
• Nonclinical Considerations for Inclusion of Pregnant and Lactating Women in Clinical Trials
• Current Topics and Updates for Pregnancy Registries
• Can Experimental Animal Studies Be Used in Counseling
• Refining Toxicology Testing to Detect Endocrine Disrupting Chemicals
• Transforming Women’s Health Through Better Information on the Safety of Medications During Pregnancy and Lactation
• Assessing Reproductive Risks from Fracking and Mountaintop Mining
• New Frontiers in Developmental Toxicity Testing for Environmental Chemicals

Education Courses:
• Education Course Session 1: Development and Disorders of the Gastrointestinal (GI) Tract - July 15, 2021 and 11:00 AM-2:30 PM
• Education Course Session 1: Development and Disorders of the Gastrointestinal (GI) Tract - July 22, 2021 and 11:00 AM-2:30 PM
• Mini Course: Single-Cell RNA Sequencing in Understanding Normal and Abnormal Development - July 29, 2021 and 11:00 AM-1:00 PM